Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer

Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer

US Patent 12247206 · Granted Mar 11, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune di2025
Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune di2025
Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune di2025
Method to identify subjects at higher risk to develop an autoimmune disease base2025
Method to identify subjects at higher risk to develop an autoimmune disease base2025
Method to identify subjects at higher risk to develop an autoimmune disease base2025
Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune di2023
Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune di2023
Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune di2023
Method of isolating circulating tumor cells2023
Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune di2021
Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune di2021